Cardiac — Absolute
ICD in place and active (no exemption program)
LVEF < 40% (any cardiac condition)
Sustained VT ≥30 sec or requiring intervention
Brugada syndrome
Long QT interval syndrome
Restrictive cardiomyopathy
Pacemaker for neurocardiogenic syncope
Rest angina or change in pattern <3 months
Neurological — Absolute
Narcolepsy (no cure; explicitly disqualifying)
Idiopathic hypersomnia
Meniere's disease
Labyrinthine fistula
Nonfunctioning labyrinth
TBI severe (penetrating dura or LOC >24 hrs)
CNS tumor — malignant or metastatic
Dementia
Psychiatric — Absolute
Active psychosis
Schizophrenia
First-generation (tricyclic) antidepressants
Medications — Absolute
Any Schedule I substance (incl. current marijuana use)
Kratom (opioid/stimulant; seizures reported)
Ropinirole (unpredictable sleep attacks)
Mirtazapine (significant impairment; typically avoid)
Vascular — Absolute
AAA symptomatic or recommended for repair
AAA growth >0.5 cm over 6 months
Thoracic aortic aneurysm >5.0 cm
PAD with pain at rest
Respiratory — Absolute
PaO₂ <65 mmHg (altitude <5,000 ft)
PaCO₂ >45 mmHg (any altitude)
Supplemental O₂ during driving (typically)
Conditional — Requires Criteria
HCM — disqualifying unless all 6 lower-risk criteria met
AAA 4–5.4 cm — disqualifying without vascular specialist clearance
ITDM — disqualifying if severe non-prolif. or prolif. retinopathy
Seizure disorder — disqualifying unless standard or exemption criteria met
Vision — disqualifying if <20/40 in better eye (corrected) or color blind
Active Monitor
Marijuana rescheduling — DEA hearing June 29 2026; DOT testing unchanged
Seizure NPRM §391.41(b)(8) — monitor federalregister.gov